These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7679228)

  • 1. More about use of the term Drb.
    Lewis M; McAlpine PJ
    Transfusion; 1993 Feb; 33(2):182. PubMed ID: 7679228
    [No Abstract]   [Full Text] [Related]  

  • 2. Location of WESb on decay-accelerating factor.
    Telen MJ; Rao N; Lublin DM
    Transfusion; 1995 Mar; 35(3):278. PubMed ID: 7533342
    [No Abstract]   [Full Text] [Related]  

  • 3. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro.
    van Dixhoorn MG; Dekker S; Janssen RW; Verbakel CA; Grosveld F
    Transplant Proc; 2000 Aug; 32(5):916-8. PubMed ID: 10936272
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of transgenic pigs expressing human DAF (CD55) regulated by the porcine MCP gene promoter.
    Murakami H; Nagashima H; Takahagi Y; Fujimura T; Miyagawa S; Okabe M; Seya T; Shigehisa T; Taniguchi N; Shirakura R; Kinoshita T
    Transplant Proc; 2000 Nov; 32(7):2505-6. PubMed ID: 11120269
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of human DAF, CD59, MCP transgene in xenotransplantation.
    Chen S; Chen G; Cai CC; Wang XM; Guo H; Shen SQ; Wang H; Wu Y; Li GX; Huang J; Li WX; Wei QX; Sun FZ
    Transplant Proc; 2001; 33(7-8):3851-2. PubMed ID: 11750639
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative roles of hCD46 and hCD55 in the regulation of hyperacute rejection.
    Verbakel CA; Bonthuis F; Eerhart SE; van Dixhoorn M; Grosveld F; Marquet RL; IJzermans JN
    Transplant Proc; 2000 Aug; 32(5):903-4. PubMed ID: 10936266
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
    Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
    Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic defect of PNH.
    Kinoshita T
    Clin Exp Immunol; 1994 Aug; 97 Suppl 2(Suppl 2):3-4. PubMed ID: 7520848
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical and genetic screening of colorectal cancer.
    Rustgi AK
    Gastroenterology; 1995 Sep; 109(3):1003-5. PubMed ID: 7544749
    [No Abstract]   [Full Text] [Related]  

  • 10. Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor.
    Atkinson JP; Oglesby TJ; White D; Adams EA; Liszewski MK
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):27-30. PubMed ID: 1718640
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (MCP), and CD55 (DAF), in hematological malignancies.
    Seya T; Matsumoto M; Hara T; Hatanaka M; Masaoka T; Akedo H
    Leuk Lymphoma; 1994 Feb; 12(5-6):395-400. PubMed ID: 7514063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma.
    Gelderman KA; Kuppen PJ; Bruin W; Fleuren GJ; Gorter A
    Eur J Immunol; 2002 Jan; 32(1):128-35. PubMed ID: 11754353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
    Yuan FF; Bryant JA; Fletcher A
    Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement.
    Parker CJ
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):36-42. PubMed ID: 1718642
    [No Abstract]   [Full Text] [Related]  

  • 15. Flow cytometric analysis of decay-accelerating factor (CD55) on neutrophils from aplastic anaemia patients.
    Forés R; Alcocer M; Diez-Martin JL; Fernandez MN
    Br J Haematol; 1995 Jul; 90(3):728-30. PubMed ID: 7544152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of complement regulating proteins on FDC.
    Schgmitz J; Petrasch S; Mews I; van Lunzen J; Kluxen B; Würzner R; Schmitz H; Racz P
    Adv Exp Med Biol; 1995; 378():293-5. PubMed ID: 8526076
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement regulatory proteins on human and porcine nontransgenic and hDAF transgenic islet cells: expression and role in susceptibility to lysis by human serum.
    Bennet W; Sundberg B; Elgue G; Brendel M; Richards A; White DJ; Groth C; Korsgren O
    Transplant Proc; 2000 Aug; 32(5):1066. PubMed ID: 10936358
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.
    Saifuddin M; Parker CJ; Peeples ME; Gorny MK; Zolla-Pazner S; Ghassemi M; Rooney IA; Atkinson JP; Spear GT
    J Exp Med; 1995 Aug; 182(2):501-9. PubMed ID: 7543140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
    Koretz K; Brüderlein S; Henne C; Möller P
    Br J Cancer; 1992 Nov; 66(5):810-4. PubMed ID: 1384641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction.
    Nowicki B; Hart A; Coyne KE; Lublin DM; Nowicki S
    J Exp Med; 1993 Dec; 178(6):2115-21. PubMed ID: 7504058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.